By Health (China) Performance
| 300146 Stock | 11.25 0.06 0.53% |
The firm owns a Beta (Systematic Risk) of -0.0495, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning By Health are expected to decrease at a much lower rate. During the bear market, By Health is likely to outperform the market. At this point, By health has a negative expected return of -0.2%. Please make sure to confirm By Health's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if By health performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days By health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Forward Dividend Yield 0.08 | Payout Ratio 0.0214 | Last Split Factor 20:10 | Forward Dividend Rate 0.9 | Ex Dividend Date 2024-04-22 |
1 | Health stocks hit after Trump taps RFK Jr for top regulator post - BBC.com | 11/15/2024 |
2 | Guardant Health Stock Focused On Future Growth, Hold - Seeking Alpha | 11/20/2024 |
3 | Health care sector outlook 2025 Health care stocks Fidelity - Fidelity Investments | 12/10/2024 |
4 | After Falling More Than 40 percent in 2024, Can CVS Health Stock Turn Things Around This Year - MSN | 01/09/2025 |
| Begin Period Cash Flow | 4.5 B |
300146 |
By Health Relative Risk vs. Return Landscape
If you would invest 1,280 in By health on November 2, 2024 and sell it today you would lose (155.00) from holding By health or give up 12.11% of portfolio value over 90 days. By health is generating negative expected returns and assumes 1.6997% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than 300146, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
By Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for By Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as By health, and traders can use it to determine the average amount a By Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.116
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 300146 |
Estimated Market Risk
| 1.7 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average By Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of By Health by adding By Health to a well-diversified portfolio.
By Health Fundamentals Growth
300146 Stock prices reflect investors' perceptions of the future prospects and financial health of By Health, and By Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 300146 Stock performance.
| Return On Equity | 0.0601 | ||||
| Return On Asset | 0.029 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 16.54 B | ||||
| Shares Outstanding | 1.7 B | ||||
| Price To Book | 1.69 X | ||||
| Price To Sales | 2.60 X | ||||
| Revenue | 9.41 B | ||||
| Gross Profit | 4.94 B | ||||
| EBITDA | 852.67 M | ||||
| Net Income | 1.75 B | ||||
| Total Debt | 2.86 B | ||||
| Book Value Per Share | 6.72 X | ||||
| Cash Flow From Operations | 2.05 B | ||||
| Earnings Per Share | 0.42 X | ||||
| Total Asset | 15.1 B | ||||
| Retained Earnings | 3.57 B | ||||
About By Health Performance
By analyzing By Health's fundamental ratios, stakeholders can gain valuable insights into By Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if By Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if By Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
By Health is entity of China. It is traded as Stock on SHE exchange.Things to note about By health performance evaluation
Checking the ongoing alerts about By Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for By health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| By health generated a negative expected return over the last 90 days | |
| By health is unlikely to experience financial distress in the next 2 years | |
| About 51.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: After Falling More Than 40 percent in 2024, Can CVS Health Stock Turn Things Around This Year - MSN |
- Analyzing By Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether By Health's stock is overvalued or undervalued compared to its peers.
- Examining By Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating By Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of By Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of By Health's stock. These opinions can provide insight into By Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 300146 Stock analysis
When running By Health's price analysis, check to measure By Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy By Health is operating at the current time. Most of By Health's value examination focuses on studying past and present price action to predict the probability of By Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move By Health's price. Additionally, you may evaluate how the addition of By Health to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |